Friday, July 7, 2023

< > Dexcom announces novel wearable for managing Type 2 diabetes without insulin

  The company told the American Diabetes Association the metabolic monitor could reduce down-the-line healthcare costs for T2 non-insulin users and others. "These trends have to change," says CEO Kevin Sayer.

No comments:

Post a Comment

< + > ŌURA Secures $200 Million in Series D Funding

Investments from Fidelity Management & Research Company and Dexcom Bring ŌURA Valuation to $5.2 Billion ŌURA , the company behind Oura ...